Once in the bloodstream, nanoparticles are distributed across different organs and tissues. The distribution depends on several factors such as particle size, shape, surface charge, and coating. Nanoparticles can accumulate in organs like the liver, spleen, kidneys, and even cross the blood-brain barrier, potentially causing adverse effects.
